Meditrina
Private Company
Funding information not available
Overview
Meditrina, founded in 2005 and headquartered in San Jose, California, has developed the Aveta System to redefine hysteroscopic tissue removal. The system integrates a single-use hysteroscope with a built-in rotating camera, fluid management, and tissue resection into a compact platform, targeting the shift of procedures from hospital operating rooms to office-based settings. Its value proposition centers on procedural efficiency, improved ergonomics for physicians, patient comfort, and cost savings by eliminating device reprocessing. The company is positioned in the competitive but growing market for minimally invasive gynecologic surgical devices.
Technology Platform
Integrated hysteroscopy suite featuring a single-use hysteroscope with SteadiView™ rotating camera technology for automatic upright image orientation, combined fluid management, and disposable tissue resection devices in a compact system.
Opportunities
Risk Factors
Competitive Landscape
The hysteroscopic tissue removal market is highly competitive, dominated by major players like Hologic (MyoSure) and Boston Scientific (TruClear). Meditrina competes by offering an all-in-one integrated system with ergonomic camera rotation and a compact footprint, targeting the specific needs of office-based procedures against competitors' often more fragmented equipment setups.